Both Magovcevic-Liebisch and Luke M. Beshar, senior vice president and chief business officer at NPS Pharmaceuticals Inc., described their firms' use of royalty financing – using anticipated future royalties as leverage to raise needed capital now

Indeed, at this month's Biocom Global Life Science Partnering Conference in San Diego, George Golumbeski, senior vice president of business development for Summit, N.J.-based Celgene, said the company decided not to follow in the footsteps of other big biotechs and pharmas that established venture capital funds

Topica Pharmaceuticals Inc., of Palo Alto, Calif., added Amir Tavakkol as senior vice president of clinical development and operations

Meanwhile at Celgene Corp., it's not only oncology but chronic inflammatory disease, according to the firm's senior vice president of business development, George Golumbeski

Some 40 percent to 60 percent of diabetics stop a new medication in the first six months, which Vince Mihalik, Amylin's senior vice president of sales and marketing and chief commercial officer, compares to a bathtub with water running out the spout and down the drain

PharmAthene Inc., of Annapolis, Md., hired Linda L. Chang as senior vice president and chief financial officer

Micromet Inc., of Rockville, Md., appointed Joseph Lobacki senior vice president and chief commercial officer...Oncolytics Biotech Inc., of Calgary, Alberta, appointed Gerard Kennealey senior vice president of clinical development and chief medical officer

Micromet Inc., of Rockville, Md., appointed Joseph Lobacki senior vice president and chief commercial officer...Oncolytics Biotech Inc., of Calgary, Alberta, appointed Gerard Kennealey senior vice president of clinical development and chief medical officer

Galleon Pharmaceuticals Inc., of Horsham, Pa., appointed Lynne M. Brookes senior vice president and chief business officer

Coronado Biosciences Inc., of Burlington, Mass., appointed Karin Hehenberger senior vice president of scientific affairs

Defendant Plaintiff Details/Decisions (Date)# Abbott (Abbott Park, Ill.) Centocor Ortho Biotech Inc. (Horsham, Pa.) Court of Appeals for the Federal Circuit in Washington overturned a 2009 federal court jury verdict that awarded Centocor $1.8 billion after finding Abbott liable for patent infringement; a panel of the court ruled that the patent relating to Centocor antitumor necrosis factor alpha rheumatoid arthritis treatments was invalid (2/24) Abbott International LLC (Queenborough, UK

Biotech Company (Location) Action Taken Details (Date)# 4SC AG (Planegg-Martinsried, Germany) 4SC is transferring almost its entire early stage research activities to a 100% subsidiary, which will operate under the name 4SC Discovery GmbH The subsidiary will focus on collaborations in the fields of drug discovery and drug optimization, as well as on commercialization; about 28 employees are expected to be transferred (12/15) Abbott (Abbott Park, Ill.) Abbott plans to separate into two publicly

AVI BioPharma Inc., of Bothell, Wash., appointed Jayant Aphale senior vice president of technical operations...Bionovo Inc., of Emeryville, Calif., added David Boyle as senior vice president and chief financial officer

Dean Tozer, senior vice president of corporate development at ADH, agreed, noting that the company often struggled to find "like-minded partners" during its formative years

Senior managers departing Cangene will be William Bees, senior vice president of operations, and Grant McClarty, vice president of R&D

A combination of good science, good collaborations, good timing and some good luck." – Mace Rothenberg, Pfizer Inc.'s senior vice president of clinical development and medical affairs in the Oncology Business Unit, on the secrets to the success of lung cancer drug Xalkori (crizotinib

Medically, as well as economically, we truly need something to get beyond that." - Chiang Li, CEO of Boston Biomedical General Wisdom "A lot of innovation is incremental, not breakthrough." - Glen Giovannetti, global biotechnology leader at Ernst & Young "I realize it's absurd to talk about 10Xs or even 5Xs these days." - Roger Longman, CEO of Real Endpoints LLC "A combination of good science, good collaborations, good timing and some good luck." - Mace Rothenberg, Pfizer Inc.'s senior vice

Yet Acceleron's senior vice president of corporate development, Steven Ertel, said the new venture money provides "more flexibility in terms of how we run the business

For its part, Momenta hopes to leverage the joint venture to expand its development of complex generic drugs while priming the pump for the discovery and development of novel drugs, according to Rick Shea, the company's senior vice president and chief financial officer